Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Not Condition-specific”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT01992861
What this trial is testing

MRI and PET Imaging in Predicting Treatment Response in Patients With Stage IB-IVA Cervical Cancer

Who this might be right for
Cervical AdenocarcinomaCervical Adenosquamous CarcinomaCervical Squamous Cell Carcinoma, Not Otherwise Specified+10 more
University of Washington 51
Early research (Phase 1)Study completedNCT01507753
What this trial is testing

Omega-3 and Therapy Study for Childhood Bipolar Disorder- Not Otherwise Specified

Who this might be right for
Bipolar Disorder
L. Eugene Arnold 23
Not applicableLooking for participantsNCT06740383
What this trial is testing

Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services

Who this might be right for
Schizophrenia Spectrum and Other Psychotic DisordersSchizophreniaDelusional Disorder+4 more
Beth Israel Deaconess Medical Center 320
Early research (Phase 1)Looking for participantsNCT06544265
What this trial is testing

SynKIR-310 for Relapsed/Refractory B-NHL

Who this might be right for
B Cell LymphomaNHL, AdultMantle Cell Lymphoma+23 more
Verismo Therapeutics 36
Post-approval studies (Phase 4)Study completedNCT02287259
What this trial is testing

Olanzapine Versus Lithium in the Treatment of Acute Depression in Patients With Bipolar II or Bipolar Not Otherwise Specified(OL Study)

Who this might be right for
Bipolar Disorder
Tadashi Hasegawa 50
Not applicableEnded earlyNCT02114827
What this trial is testing

Efficacy of a Patient Education Video

Who this might be right for
Leukemia, Not Otherwise SpecifiedMalignant Neoplasm
Virginia Commonwealth University 9
Large-scale testing (Phase 3)Study completedNCT00956813
What this trial is testing

Flaxseed in Treating Postmenopausal Women With Hot Flashes Who Have a History of Breast Cancer or Other Cancer or Who Do Not Wish to Take Estrogen Therapy

Who this might be right for
Breast CancerHot FlashesMenopausal Symptoms+1 more
Alliance for Clinical Trials in Oncology 210
Not applicableStudy completedNCT02497027
What this trial is testing

Pharmacogenetic Testing in an Outpatient Population of Patients With Depression

Who this might be right for
Depression
Avera McKennan Hospital & University Health Center 83
Not applicableWithdrawnNCT00052221
What this trial is testing

Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy

Who this might be right for
FatigueUnspecified Adult Solid Tumor, Protocol Specific
M.D. Anderson Cancer Center
Early research (Phase 1)Active Not RecruitingNCT06014762
What this trial is testing

P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies

Who this might be right for
Diffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh-grade B-cell LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)+7 more
Poseida Therapeutics, Inc. 120
Early research (Phase 1)Not Yet RecruitingNCT07691450
What this trial is testing

Belinostat in Combination With Azacitidine or Pralatrexate for the Treatment of Relapse or Refractory T-cell Lymphoma

Who this might be right for
Recurrent Anaplastic Large Cell LymphomaRecurrent Enteropathy-Associated T-Cell LymphomaRecurrent Follicular Helper T-Cell Lymphoma+23 more
City of Hope Medical Center 40
Not applicableStudy completedNCT00919750
What this trial is testing

Collecting and Storing Blood and Brain Tumor Tissue Samples From Children With Brain Tumors

Who this might be right for
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System Germ Cell TumorChildhood Cerebral Anaplastic Astrocytoma+17 more
Children's Oncology Group 1,258
Testing effectiveness (Phase 2)Study completedNCT02095132
What this trial is testing

Adavosertib and Irinotecan Hydrochloride in Treating Younger Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Central Nervous System Embryonal Tumor With Rhabdoid FeaturesCentral Nervous System Embryonal Tumor, Not Otherwise SpecifiedCentral Nervous System Ganglioneuroblastoma+12 more
National Cancer Institute (NCI) 76
Not applicableStudy completedNCT03040206
What this trial is testing

Risk Stratification of Nodal PTCL

Who this might be right for
Peripheral T-Cell Lymphoma, Not Otherwise SpecifiedAngioimmunoblastic T-cell LymphomaAnaplastic Large Cell Lymphoma, ALK-negative
Chonbuk National University Hospital 405
Testing effectiveness (Phase 2)Looking for participantsNCT06536049
What this trial is testing

Epcoritamab Plus Ibrutinib for the Treatment of Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma

Who this might be right for
Recurrent Diffuse Large B-Cell LymphomaRecurrent Grade 3b Follicular LymphomaRecurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements+11 more
Yazeed Sawalha 38
Not applicableLooking for participantsNCT07771335
What this trial is testing

The Erlanger Stroke Project is an Ongoing Prospective Population-based Stroke Registry in Germany, Including All Hospitalized and Nonhospitalized Patients With Stroke in the City of Erlangen (120.000 Inhabitants).

Who this might be right for
Intracerebral Haemorrhage (ICH)Cerebral InfarctionCerebral Infarction Due to Thrombosis of Cerebral Arteries+6 more
University of Erlangen-Nürnberg Medical School 17,000
Not applicableNot Yet RecruitingNCT06797570
What this trial is testing

The Primary Objective of This Study is to Determine Whether Positively Framed Information (PFI) on Side Effects, Compared to Negatively Framed and Extensive Information (NFI) Can Reduce the Number and Severity of Reported Adverse Events Caused by ADHD Medication in Children Aged 7 to 17 Years.

Who this might be right for
Attention Deficit DisorderAttention Deficit Disorder (ADD)Attention Deficit Disorder with Hyperactivity+13 more
St. Antonius Hospital
Testing effectiveness (Phase 2)WithdrawnNCT04795869
What this trial is testing

Brentuximab Vedotin and Pembrolizumab in Treating Patients With Recurrent Peripheral T-Cell Lymphoma

Who this might be right for
Recurrent Angioimmunoblastic T-Cell LymphomaRecurrent Enteropathy-Associated T-Cell LymphomaRecurrent Follicular T-Cell Lymphoma+11 more
Northwestern University
Early research (Phase 1)Not Yet RecruitingNCT07649304
What this trial is testing

AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")

Who this might be right for
AIDS-Related Diffuse Large B-cell LymphomaDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedHigh Grade B-Cell Lymphoma With MYC and BCL2 Rearrangements+6 more
National Cancer Institute (NCI) 15
Early research (Phase 1)Study completedNCT00544284
What this trial is testing

Bortezomib and Temozolomide in Treating Patients With Brain Tumors or Other Solid Tumors That Have Not Responded to Treatment

Who this might be right for
Brain and Central Nervous System TumorsLymphomaMetastatic Cancer+1 more
City of Hope Medical Center 25
Next Page
130